Guinea-Bissau vs South Africa: Population requiring preventive chemotherapy for schistosomiasis
Guinea-Bissau
399,321
in 2024
South Africa
506,732
in 2024
Guinea-Bissau rank
41st
South Africa rank
39th
Population requiring preventive chemotherapy for schistosomiasis over time
- Guinea-Bissau
- South Africa
How they compare
South Africa currently reports 506,732 against 399,321 in Guinea-Bissau, a difference of 107,411.
That makes South Africa's figure about 1.3 times Guinea-Bissau's.
Across all 15 years both countries report, South Africa has been ahead every year.
Guinea-Bissau ranks 41st and South Africa ranks 39th of 52 countries.
South Africa has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guinea-Bissau | South Africa | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 219,316 | 5.28 million | 5.06 million | South Africa |
| 2020s | 221,684 | 2.98 million | 2.76 million | South Africa |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Guinea-Bissau or South Africa?
- South Africa, at 506,732 against 399,321 in Guinea-Bissau as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Guinea-Bissau and South Africa?
- 107,411, with South Africa ahead.
- How many years of comparable data are there for Guinea-Bissau and South Africa?
- 15 years are reported by both, from 2010 to 2024.
- How do Guinea-Bissau and South Africa rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Guinea-Bissau ranks 41st and South Africa ranks 39th of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.